Erratum: Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2 -positive breast cancers before and after trastuzumab era: results from a real-life cohort

Correction to: British Journal of Cancer (2016) 114, 45–52. doi:10.1038/bjc.2015.426; published online 10 December 2015 The first author of this article is incorrectly listed as Anne-Sophie Hamy-Petit in the original article and should be Anne-Sophie Hamy. This work is published under the standard license to publish agreement.